These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29192108)

  • 1. Bad Medicine: Polypharmacy.
    Spence D
    Br J Gen Pract; 2017 Dec; 67(665):562. PubMed ID: 29192108
    [No Abstract]   [Full Text] [Related]  

  • 2. No more free drug samples?
    Chimonas S; Kassirer JP
    PLoS Med; 2009 May; 6(5):e1000074. PubMed ID: 19434227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US drug marketing: how does promotion correspond with health value?
    Greenway T; Ross JS
    BMJ; 2017 May; 357():j1855. PubMed ID: 28465309
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of a drug.
    Kaebnick GE
    Hastings Cent Rep; 2008; 38(5):2. PubMed ID: 18947124
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regress for expensive medicines? When costly therapies are not a problem].
    Nitz G
    MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
    [No Abstract]   [Full Text] [Related]  

  • 9. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "no to greed".
    Hunt DP
    South Med J; 2015 Jan; 108(1):65-6. PubMed ID: 25580762
    [No Abstract]   [Full Text] [Related]  

  • 13. Polypharmacy and patterns of prescription medication use among cancer survivors.
    Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
    Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are free drug samples in the best interest of our patients?
    Quigley TF
    JAAPA; 2010 Nov; 23(11):15. PubMed ID: 21086882
    [No Abstract]   [Full Text] [Related]  

  • 15. Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):70-76. PubMed ID: 30325706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pricing of prescription drugs and its impact on physicians' choice behavior.
    Miao-Sheng C; Yu-Ti S
    Health Care Manag Sci; 2008 Sep; 11(3):288-95. PubMed ID: 18826006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan.
    Liu YM
    Int Health; 2020 Jul; 12(4):272-280. PubMed ID: 31647555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care.
    King AC; Schwartz LM; Woloshin S
    JAMA Intern Med; 2020 Apr; 180(4):592-595. PubMed ID: 31985742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
    Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
    JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.